Recent Articles from GlobeNewswire

SUIZHOU, China, May 23, 2025 (GLOBE NEWSWIRE) -- A grand ancestral worship festival in the hometown of Chinese Yan Emperor was held in Suizhou, central China's Hubei Province, on May 23.

Geneva, Switzerland, May 23, 2025 (GLOBE NEWSWIRE) -- Global health leaders call for urgent, integrated action on the rising rates of metabolic liver disease during a high-level policy event held on the sidelines of the 78th World Health Assembly and co-hosted by Global Liver Institute (GLI), the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD). This event brought together leading experts, policymakers, public health officials, and advocates to push for stronger public health strategies that address liver disease as part of the global noncommunicable diseases (NCDs) response and highlight the need to embed liver health within national NCD strategies.

Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today reported financial information for the first quarter of 2025, including its cash, cash equivalents and revenues.

Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the results of the votes of its Combined Shareholders’ Meeting.  

 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE IT IS UNLAWFULTO DO SO

ENDEAVOUR ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING 2025

FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025

The 2025 Belt and Road Youth Sports Exchange Week (Jiangsu)

OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025

Cherry Hill, NJ, May 23, 2025 (GLOBE NEWSWIRE) -- Aurio, an innovative business services company, has expanded its offerings with the launch of a new Finance Operations segment, delivering a full finance stack to help clients manage financial performance with a strategic focus. The segment, which debuted last month, offers a comprehensive suite of financial services, including bookkeeping, finance operations consulting, and CFO services.

ATHENS, Greece, May 23, 2025 (GLOBE NEWSWIRE) -- De Havilland Aircraft of Canada Limited (“De Havilland Canada”) is pleased to announce the launch of De Havilland Aircraft of Canada Hellas Ltd., its new wholly-owned subsidiary in Greece, further strengthening our commitment to providing exceptional customer support to our valued customers in the region. This expansion also reflects De Havilland Canada’s deep confidence in the Greek market and its strong cooperation with the Greek government and the relevant aviation authorities.

Backed by 300% user growth, Bitget Wallet unveils a new design and $1M campaign to bring crypto into everyday use worldwide

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ:ADTN) on behalf of ADTRAN stockholders. Our investigation concerns whether ADTRAN has violated the federal securities laws and/or engaged in other unlawful business practices.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ:SMLR) on behalf of Semler stockholders. Our investigation concerns whether Semler has violated the federal securities laws and/or engaged in other unlawful business practices.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Intellia Therapeutics, Inc. (NASDAQ:NTLA) on behalf of long-term stockholders following a class action complaint that was filed against Intellia on February 11, 2025 with a Class Period from July 30, 2024 to January 8, 2025. Our investigation concerns whether the board of directors of Intellia have breached their fiduciary duties to the company.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Apple Inc. (“Apple” or the “Company”) (NASDAQ:AAPL) on behalf of Apple stockholders. Our investigation concerns whether Apple has violated the federal securities laws and/or engaged in other unlawful business practices.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (OTC: LUNA) on behalf of long-term stockholders following a class action complaint that was filed against Luna Innovation on April 1, 2024 with a Class Period from August 11, 2023 to March 25, 2024. Our investigation concerns whether the board of directors of Luna Innovation have breached their fiduciary duties to the company.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) on behalf of Fulgent stockholders. Our investigation concerns whether Fulgent has violated the federal securities laws and/or engaged in other unlawful business practices.

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of 2,222,222 shares of its common stock at a public offering price of $9.00 per share. In addition, Gyre has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 333,333 shares of its common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds of the offering to Gyre, before deducting the underwriting discounts and commissions and other offering expenses payable by Gyre, are expected to be approximately $20.0 million. The offering is expected to close on or about May 27, 2025, subject to the satisfaction of customary closing conditions.

BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- CECOCECO, a leading innovator in the lighting and display industry, is excited to announce its participation in the AIA Conference on Architecture & Design 2025, taking place from June 4-7 in Boston. At Booth #1119, CECOCECO will present the latest edition of ArtMorph—an innovative luminous wall panel that seamlessly blends LED display technology with textures.

ROCKVILLE, Md. and SUZHOU, China, May 22, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, today announced that new clinical data from two ongoing investigational studies evaluating lisaftoclax in various blood cancers and alrizomadlin in solid tumors will be presented during an oral presentation and poster presentation, respectively, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 - June 3 in Chicago, Ill., USA. Both lisaftoclax and alrizomadlin demonstrated antitumor activity, and the data support their further clinical development.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, ranosidenib, fruquintinib and surufatinib, will be presented at the American Society of Clinical Oncology (“ASCO”) Annual Meeting taking place on May 30 – June 3, 2025 in Chicago, USA.

Dallas, TX, May 22, 2025 (GLOBE NEWSWIRE) -- ZEBRA, the personal care brand founded by clean wellness advocate Jenn Thatcher, has officially expanded into the beauty space with the launch of THE LIP GLOSS - CLEAR, a high-shine, non-toxic gloss designed for long-lasting hydration and a mirror-like finish.

SYDNEY and HONG KONG, May 22, 2025 (GLOBE NEWSWIRE) -- AI-Media Technologies Limited ("AI-Media"), a global leader in live captioning and translation solutions, has entered a groundbreaking partnership with Lightning International ("Lightning"), the leading distributor of Free Ad-Supported Television (FAST) channels. This collaboration aims to break down barriers and bring the joy of entertainment to every corner of the globe, and enhance revenue opportunities for FAST platforms and content owners, transforming how premium content is distributed and monetized across diverse markets.

WASHINGTON, May 22, 2025 (GLOBE NEWSWIRE) -- On May 22, PepsiCo announced it is abandoning its reuse goal: to achieve 20% of all beverage servings the company sells be sold through reusable models by 2030. In addition, the company ended its goal to “cut virgin plastic from non-renewable sources per serving” and scaled back other goals related to its plastic packaging use. PepsiCo reported in 2023 that the company’s share of packaging in reusable formats was 10%, unchanged from when it first announced its goal in 2022.

DUBAI, United Arab Emirates, May 23, 2025 (GLOBE NEWSWIRE) -- Michelin celebrated the city's culinary excellence like never before at Dubai’s fourth MICHELIN Guide Ceremony, held at Address Sky View. The event revealed 119 establishments, covering over 35 cuisine types, which made it into this year’s selection, showcasing the city’s booming gastronomic scene.

KELLOGG, Idaho and VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR |OTCQB: BHLL) is pleased to announce that the Company and Teck Resources Limited (“Teck”) have agreed to amend and restate the unsecured promissory note previously provided by Teck to increase the maximum aggregate principal amount thereunder from US$3.4 million to US$4.4 million (as amended and restated, the “Promissory Note”). The Promissory Note ensures sufficient short-term funding until the previously announced brokered and non-brokered private placements close, and bears interest at a rate of 12% per annum, with such interest being capitalized and added to the principal amount outstanding monthly under the Promissory Note. The Promissory Note is available in multiple advances, at the discretion of Teck, and is payable by the Company in cash on demand from Teck. No bonus securities of the Company will be issued to Teck in connection with the Promissory Note, nor is the Promissory Note convertible into securities of the Company.

Global leader in human spaceflight and aerospace services to operate a 45,000-square-foot astronaut food innovation facility at Exploration Park on NASA’s Johnson Space Center

LAUREL, Md., May 22, 2025 (GLOBE NEWSWIRE) -- The Coastal Companies is issuing a voluntary recall of 17 products that were produced from cucumbers grown by Bedner Growers, Inc. and distributed by Fresh Start Produce Sales, Inc. due to the potential for Salmonella contamination. These products were distributed by East Coast Fresh in Laurel, MD and Hearn Kirkwood in Jessup, MD.

HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR), a leader in human spaceflight expertise for more than 60 years, has signed a letter of intent with ACMI Properties to grow KBR’s commercial space capabilities including a human spaceflight food laboratory at NASA’s Exploration Park, adjacent to Johnson Space Center. The 45,000 square-foot, Houston-based facility would serve the growing commercial low-Earth orbit (LEO) industry where tailorable astronaut food systems and solutions will be designed, tested, validated, produced, and integrated into customer mission environments.

One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20%

-  63% response rate observed among 43 evaluable patients

SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced the publication of two abstracts on the American Society of Clinical Oncology (ASCO) website in advance of the 2025 ASCO Annual Meeting, taking place May 30-June 3 in Chicago, Illinois.

BROOKINGS, S.D., May 22, 2025 (GLOBE NEWSWIRE) -- Daktronics, Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide today announced that Brad Wiemann, Interim Chief Executive Officer and Howard Atkins, Acting Chief Financial Officer will participate in the Craig-Hallum Capital Group’s 22nd Annual Institutional Investor Conference to be held Wednesday, May 28th, 2025 in Minneapolis, MN.

ImCheck Reports High Remission Rates in AML Patientswith ICT01 Combination Therapy at ASCO 2025

CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), Taiho Pharmaceutical Co., Ltd., and Taiho Oncology, Inc. today announced new positive results from the pivotal Phase 2b cohorts of the REZILIENT1 trial, a Phase 1/2 clinical trial of zipalertinib monotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (ex20ins) who have received prior therapy. These data will be presented on Sunday, June 1 at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting as an oral presentation during the “Lung Cancer – Non-Small Cell Metastatic” session from 9:00 AM-9:12 AM CDT (Abstract #8503).

SOMERSET, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new data evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for patients living with multiple myeloma will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2025 European Hematology Association’s (EHA) Congress. Preliminary results from Phase 1 LB2102 and Phase 1 LB1908 ongoing dose-escalation studies in solid tumors, specifically lung and gastric cancers respectively, will also be featured in poster presentations at ASCO.

FLORENCE, Italy and NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, will present updated preliminary efficacy and safety results from the Phase 1b/2 ELEVATE study in patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) locally advanced or metastatic breast cancer (mBC). The ELEVATE study was designed to evaluate the safety and efficacy of oral-oral combination treatment options to overcome different resistance mechanisms observed in ER+/HER2- mBC and improve patient outcomes. Additionally, various other trial-in-progress updates will be presented, investigating elacestrant’s potential to become an endocrine therapy (ET) backbone across the spectrum of breast cancer. These data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

Santa Clara, CA and Kyoto, Japan, May 22, 2025 (GLOBE NEWSWIRE) -- ROHM Semiconductor today announced an expanded portfolio of surface-mount near-infrared (NIR) LEDs with new compact top-view types optimized for applications such as VR/AR devices, industrial optical sensors, and human detection sensors.

NEEDHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that results from the Company’s positive phase 3 clinical trial of aglatimagene besadenovec (CAN-2409) in patients with intermediate-to-high-risk localized prostate cancer will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Chicago, IL, from May 30 to June 3, 2025.

Ingelheim, Germany, 22 May 2025 – Boehringer Ingelheim today announced that new clinical data from two early-stage trials targeting the signal regulatory protein α (SIRPα) innate immune checkpoint will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, May 30 - June 3, 2025, in Chicago, IL, USA. 

CTLA-4 inhibitor ADG126 can be dosed at 20 mg/kg Q6W in combination with pembrolizumab with <20% Grade 3 adverse events

Novel TROP2-targeting AVC-Booster demonstrated prolonged and significantly improved tumor control in animal models, and activation of the full immune system in non-small cell lung cancer patient samples

MINNEAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- The Sustainable Forestry Initiative (SFI) is pleased to announce The Lyme Timber Company as the recipient of the 2025 SFI Leadership in Conservation Award. Lyme Timber, certified to the SFI Forest Management Standard, is being recognized for a longstanding commitment to advancing conservation outcomes across its land base. SFI specifically recognizes Managing Directors Peter Stein and Sean Ross for their instrumental leadership in partnering on meaningful conservation efforts related to biodiversity conservation, research-based forest management practices, and climate smart forestry.

New data from the INSIGHT study demonstrates the VeriStrat Host Immune Classifier (HIC)’s ability to predict overall survival in patients with non-small cell lung cancer treated with immunotherapy

First results to be presented in two ASCO oral presentations

Company to host conference call on Sunday, June 1, 2025 at 3:00 p.m. CT / 4:00 p.m. ET to discuss fulsome dataset

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced multiple presentations related to its oncology programs at upcoming medical conferences, including the American Society of Clinical Oncology (ASCO) Annual Meeting, and the European Society of Medical Oncology (ESMO) Gynaecological Cancers Congress.

Menlo Park, CA, May 22, 2025 (GLOBE NEWSWIRE) -- Cal Redwood Acquisition Corp. (the “Company”) announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit on May 22, 2025. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol “CRAQU” beginning May 23, 2025. Each unit consists of one Class A ordinary share and one right to receive one tenth of a Class A ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and rights will be listed on the Nasdaq Global Market under the symbols “CRA” and “CRAQR,” respectively. The offering is expected to close on May 27, 2025, subject to customary closing conditions.

Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on May 20, 2025 indicating that the Company’s failure to file its Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the “10-Q”) is in violation of Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”).

COLUMBIA, Md., May 22, 2025 (GLOBE NEWSWIRE) -- Howard Community College (HCC) President Daria J. Willis today announced more than $83,000 of cleared institutional balances for graduating and continuing students at the institution. 

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) --

The Organizing Committee of Sanmenxia Yellow River Cultural Tourism Festival

Relative value opportunities in volatile spread environment

PRAGUE and BRATISLAVA, Czech Republic, May 22, 2025 (GLOBE NEWSWIRE) -- ESET has participated in a major infrastructure disruption of the notorious infostealer, Danabot, by the US Department of Justice, the FBI, and US Department of Defense’s Defense Criminal Investigative Service. U.S. agencies were working closely with Germany’s Bundeskriminalamt, the Netherlands' National Police, and the Australian Federal Police. ESET took part in the effort alongside Amazon, CrowdStrike, Flashpoint, Google, Intel471, PayPal, Proofpoint, Team Cymru and Zscaler. ESET Research, which has been tracking Danabot since 2018, contributed assistance that included providing technical analysis of the malware and its backend infrastructure, as well as identifying Danabot’s C&C servers. During that period, ESET analyzed various Danabot campaigns all over the world, with Poland, Italy, Spain and Turkey historically being one of the most targeted countries. The joint takedown effort also led to the identification of individuals responsible for Danabot development, sales, administration, and more.

LONDON, May 22, 2025 (GLOBE NEWSWIRE) -- On May 19, 2025, Crown LNG Holdings Limited (the “Company”)  (NASDAQ: CGBS), received a letter (the “Letter”) from The NASDAQ Stock Market LLC (“NASDAQ”) indicating that, as a result of not having timely filed its Annual Report on Form 20-F for the period ended December 31, 2024 (the “20-F”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with NASDAQ Listing Rule 5250(c)(1), which requires timely filing of all required financial reports with the SEC.

WEST DES MOINES, Iowa, May 22, 2025 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”) announced that it has declared the following preferred stock dividends on its non-cumulative preferred stock (represented by depositary shares, each representing a 1/1,000th interest in a share of preferred stock), payable on June 30, 2025 to holders of record as of June 15, 2025.

HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced that it will host a live conference call and audio webcast on Thursday, May 29, 2025 at 8:30 a.m. ET to provide a comprehensive business overview.

New York, NY, May 22, 2025 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) today announced that the company’s Board of Directors has declared a quarterly dividend on IPG common stock of $0.33 per share, payable on June 16, 2025, to holders of record at the close of business on June 2, 2025.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) --

Washington, DC, May 22, 2025 (GLOBE NEWSWIRE) -- USAging and more than 50 other national aging and health-focused organizations and enterprises have called upon Congress to protect the federal Older Americans Act (OAA) in a letter sent today to the leaders of the committees of jurisdiction for the OAA. The letter calls attention to a proposal to break apart OAA services under the Department of Health and Human Services (HHS) reorganization.

LITTLE ROCK, Ark., May 22, 2025 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Senior Vice President, Chief Financial Officer and Treasurer, Paul Bullington, and Senior Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the Goldman Sachs 10th Annual Leveraged Finance and Credit Conference on May 29, 2025 in Dana Point, CA.

HONG KONG, May 22, 2025 (GLOBE NEWSWIRE) -- Everbright Digital Holdings Limited (the “Company” or “Everbright”) (Nasdaq: EDHL), an integrated marketing solutions provider headquartered in Hong Kong, today announced that it has issued an additional 160,000 ordinary shares (the “Ordinary Shares”) at a price of US$4.00 per share for gross proceeds of approximately $640,000, before deducting underwriter discounts and other related expenses, pursuant to the partial exercise of the underwriter’s over-allotment option in connection with the Company’s previously announced initial public offering (the “Offering”). The option closing date was May 22, 2025. The ordinary shares began trading on the Nasdaq Capital Market on April 17, 2025, under the ticker symbol “EDHL”.

HOUSTON, TEXAS, May 22, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its second quarter 2025 results on Thursday, June 5, 2025, after trading closes on the New York Stock Exchange.

Dallas, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 26, 2025 to stockholders of record at the close of business on June 9, 2025.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) --

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) --

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) --

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its cash position as of March 31, 2025 and revenues for the first three months of 2025.1

Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) --

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) --

Luxembourg, Grand Duchy of Luxembourg, May 22, 2025 - (GLOBE NEWSWIRE) Codere Online Luxembourg, S.A. (“Codere Online” or the “Company”) (Nasdaq: CDRO / CDROW), today announced that, on May 16, 2025, it received a staff determination letter (the "Letter"), from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company of the determination from the Nasdaq Staff (the "Staff") to delist the Company's securities from The Nasdaq Stock Market, given the Company had not filed its Form 20-F for the year ended December 31, 2024 (the “2024 Form 20-F”) in accordance with continued Listing Rule 5250(c)(1) (the “Public Reports Rule”). As previously reported, the Company’s delay in filing its 2024 Form 20-F is due to the fact that the finalization of the audit of the Company’s financial statements for the year ended December 31, 2024 has taken longer than expected following the engagement of the Company’s new independent registered public accounting firm on December 31, 2024 and the Company’s diligent efforts to finalize the Form 20-F for the year ended December 31, 2023, which the Company filed with the Securities and Exchange Commission (“SEC”) on May 1, 2025.